A Small-Molecule Screening Strategy To Identify Suppressors of Statin Myopathy
- 6 July 2011
- journal article
- letter
- Published by American Chemical Society (ACS) in ACS Chemical Biology
- Vol. 6 (9) , 900-904
Abstract
The reduction of plasma low-density lipoprotein levels by HMG-CoA reductase inhibitors, or statins, has had a revolutionary impact in medicine, but muscle-related side effects remain a dose-limiting toxicity in many patients. We describe a chemical epistasis approach that can be useful in refining the mechanism of statin muscle toxicity, as well as in screening for agents that suppress muscle toxicity while preserving the ability of statins to increase the expression of the low-density lipoprotein receptor. Using this approach, we identified one compound that attenuates the muscle side effects in both cellular and animal models of statin toxicity, likely by influencing Rab prenylation. Our proof-of-concept screen lays the foundation for truly high-throughput screens that could help lead to the development of clinically useful adjuvants that can one day be co-administered with statins.Keywords
This publication has 24 references indexed in Scilit:
- A phase I trial of UCN-01 and prednisone in patients with refractory solid tumors and lymphomasCancer Chemotherapy and Pharmacology, 2009
- Statin‐induced muscle damage and atrogin‐1 induction is the result of a geranylgeranylation defectThe FASEB Journal, 2009
- Large-scale chemical dissection of mitochondrial functionNature Biotechnology, 2008
- The muscle-specific ubiquitin ligase atrogin-1/MAFbx mediates statin-induced muscle toxicityJournal of Clinical Investigation, 2007
- ChemBank: a small-molecule screening and cheminformatics resource databaseNucleic Acids Research, 2007
- Rab‐small GTPases are involved in fluvastatin and pravastatin‐induced vacuolation in rat skeletal myofibersThe FASEB Journal, 2007
- The Role of Coenzyme Q10 in Statin-Associated MyopathyJACC, 2007
- Chemical genetics identifies Rab geranylgeranyl transferase as an apoptotic target of farnesyl transferase inhibitorsCancer Cell, 2005
- HMG CoA Reductase Inhibitor-Induced Myotoxicity: Pravastatin and Lovastatin Inhibit the Geranylgeranylation of Low-Molecular-Weight Proteins in Neonatal Rat Muscle Cell CultureToxicology and Applied Pharmacology, 1997
- Lowering Plasma Cholesterol by Raising LDL ReceptorsNew England Journal of Medicine, 1981